The number of major alliances between large biopharmaceutical companies and smaller biotech firms or academic institutes is soaring. Yet the latest bio-partnering study conducted by IBM and Silico Research shows that many life sciences companies still struggle to collaborate effectively. There are four steps such companies can take to enhance their appeal. They can capitalize on areas of existing expertise to attract new partners; "sweeten" an offer with non-financial incentives; adopt a project-oriented perspective; and develop the skills to engage in different kinds of partnerships.
Read the full report - link
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment